| Fund Name | Location |
| Asatsu DK | Hokkaido Prefecture, Japan, Sapporo |
| Clearly Social Angels | England, London, United Kingdom |
| Dera Game | Japan, Tokyo |
| Hayan Health Networks | California, San Francisco, United States |
| Huamei International | China, Guangdong, Guangzhou |
| Huaou Equity Investment | China, Hangzhou, Zhejiang |
| Kudan | Japan, Tokyo |
| Matrix Capital Management | Massachusetts, United States, Waltham |
| Pappas Capital | Durham, North Carolina, United States |
| Rex Health Ventures | North Carolina, Raleigh, United States |
| Shantou Dongfeng Venture Capital | China, Guangdong, Shantou |
| Shenzhen Bingchuan Network | China, Guangdong, Tianjin |
| Syndicat Technologies | - |
| Taleria Ventures | - |
| Tamar Ventures | Herzliya, Israel, Tel Aviv |
| TEV | Tengelmann Ventures | Essen, Germany, Nordrhein-Westfalen |
| Tri-State Investment Group | Chapel Hill, North Carolina, United States |
| Var Business Angels | France, Provence-Alpes-Cote d'Azur, Toulon |
| Walvax Biotechnology | China, Kunming, Yunnan |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
DeepLook Medical | $1M | 08 Feb 2024 | New Haven, Connecticut, United States | ||
Torigen Pharmaceuticals | $13M | 16 Nov 2022 | Farmington, Connecticut, United States | ||
VeraDermics | $20M | 22 Sep 2021 | San Antonio, Texas, United States | ||
Medrhythms | $25M | 28 Jul 2021 | Boston, Massachusetts, United States | ||
Bastion | $2M | 05 Oct 2020 | Connecticut, United States | ||
Likarda | $4M | 28 Aug 2017 | Kansas City, Kansas, United States |
– MedRhythms announced the closing of a $25m Series B financing round co-led by Morningside Ventures and Advantage Capital, with participation from existing investor Werth Family Investment Associates.
– The proceeds from the Series B financing will enable MedRhythms to expand its team and key corporate functions as the company commercializes its flagship product for chronic stroke survivors with walking deficits and advances its digital therapeutics pipeline.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
DeepLook Medical | $1M | 08 Feb 2024 | New Haven, Connecticut, United States | ||
Torigen Pharmaceuticals | $13M | 16 Nov 2022 | Farmington, Connecticut, United States | ||
VeraDermics | $20M | 22 Sep 2021 | San Antonio, Texas, United States | ||
Medrhythms | $25M | 28 Jul 2021 | Boston, Massachusetts, United States | ||
Bastion | $2M | 05 Oct 2020 | Connecticut, United States | ||
Likarda | $4M | 28 Aug 2017 | Kansas City, Kansas, United States |
